Original
Tratamiento de la psoriasis en placas moderada a grave con fármacos biológicos: análisis del sobrecoste de la intensificación temporal frente a cambio a otro biológico en caso de fracaso secundario
Treatment of Moderate to Severe Plaque Psoriasis With Biologics: Analysis of the Additional Cost of Temporary Dose Escalation vs Switch to Another Biologic After Failure of Maintenance Therapy
L. Puig
Servicio deDermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España
Leído
9206
Vecesse ha leído el artículo
2957
Total PDF
6249
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 126 | 22 | 148 |
| 2025 5 | 113 | 30 | 143 |
| 2025 4 | 111 | 25 | 136 |
| 2025 3 | 96 | 22 | 118 |
| 2025 2 | 124 | 33 | 157 |
| 2025 1 | 69 | 21 | 90 |
| 2024 12 | 66 | 25 | 91 |
| 2024 11 | 76 | 57 | 133 |
| 2024 10 | 83 | 43 | 126 |
| 2024 9 | 59 | 26 | 85 |
| 2024 8 | 94 | 108 | 202 |
| 2024 7 | 80 | 45 | 125 |
| 2024 6 | 101 | 59 | 160 |
| 2024 5 | 62 | 35 | 97 |
| 2024 4 | 82 | 29 | 111 |
| 2024 3 | 56 | 35 | 91 |
| 2024 2 | 62 | 34 | 96 |
| 2024 1 | 46 | 28 | 74 |
| 2023 12 | 59 | 30 | 89 |
| 2023 11 | 78 | 26 | 104 |
| 2023 10 | 46 | 23 | 69 |
| 2023 9 | 55 | 33 | 88 |
| 2023 8 | 33 | 21 | 54 |
| 2023 7 | 78 | 32 | 110 |
| 2023 6 | 73 | 27 | 100 |
| 2023 5 | 75 | 23 | 98 |
| 2023 4 | 41 | 16 | 57 |
| 2023 3 | 91 | 30 | 121 |
| 2023 2 | 63 | 24 | 87 |
| 2022 1 | 55 | 30 | 85 |
| 2022 12 | 75 | 34 | 109 |
| 2022 11 | 124 | 41 | 165 |
| 2022 10 | 93 | 42 | 135 |
| 2022 9 | 50 | 54 | 104 |
| 2022 8 | 55 | 58 | 113 |
| 2022 7 | 57 | 48 | 105 |
| 2022 6 | 42 | 40 | 82 |
| 2022 5 | 44 | 43 | 87 |
| 2022 4 | 56 | 29 | 85 |
| 2022 3 | 49 | 43 | 92 |
| 2022 2 | 44 | 30 | 74 |
| 2021 1 | 55 | 47 | 102 |
| 2021 12 | 52 | 44 | 96 |
| 2021 11 | 80 | 48 | 128 |
| 2021 10 | 48 | 49 | 97 |
| 2021 9 | 41 | 60 | 101 |
| 2021 8 | 58 | 42 | 100 |
| 2021 7 | 73 | 45 | 118 |
| 2021 6 | 57 | 41 | 98 |
| 2021 5 | 68 | 43 | 111 |
| 2021 4 | 109 | 87 | 196 |
| 2021 3 | 59 | 44 | 103 |
| 2021 2 | 57 | 41 | 98 |
| 2020 1 | 63 | 30 | 93 |
| 2020 12 | 37 | 13 | 50 |
| 2020 11 | 29 | 18 | 47 |
| 2020 10 | 46 | 29 | 75 |
| 2020 9 | 55 | 22 | 77 |
| 2020 8 | 43 | 26 | 69 |
| 2020 7 | 42 | 9 | 51 |
| 2020 6 | 40 | 16 | 56 |
| 2020 5 | 48 | 20 | 68 |
| 2020 4 | 44 | 14 | 58 |
| 2020 3 | 26 | 15 | 41 |
| 2020 2 | 4 | 7 | 11 |
| 2020 1 | 4 | 4 | 8 |
| 2019 12 | 7 | 11 | 18 |
| 2019 11 | 4 | 1 | 5 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 9 | 1 | 10 |
| 2019 8 | 4 | 4 | 8 |
| 2019 7 | 2 | 8 | 10 |
| 2019 6 | 6 | 10 | 16 |
| 2019 5 | 1 | 32 | 33 |
| 2019 4 | 0 | 31 | 31 |
| 2019 3 | 13 | 10 | 23 |
| 2019 2 | 4 | 4 | 8 |
| 2019 1 | 2 | 4 | 6 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 1 | 7 | 8 |
| 2018 10 | 7 | 8 | 15 |
| 2018 9 | 4 | 1 | 5 |
| 2018 8 | 0 | 7 | 7 |
| 2018 7 | 0 | 7 | 7 |
| 2018 6 | 1 | 4 | 5 |
| 2018 5 | 2 | 8 | 10 |
| 2018 4 | 0 | 5 | 5 |
| 2018 3 | 14 | 9 | 23 |
| 2018 2 | 59 | 11 | 70 |
| 2018 1 | 61 | 13 | 74 |
| 2017 12 | 73 | 12 | 85 |
| 2017 11 | 81 | 21 | 102 |
| 2017 10 | 72 | 13 | 85 |
| 2017 9 | 54 | 10 | 64 |
| 2017 8 | 77 | 19 | 96 |
| 2017 7 | 87 | 22 | 109 |
| 2017 6 | 58 | 28 | 86 |
| 2017 5 | 87 | 19 | 106 |
| 2017 4 | 228 | 19 | 247 |
| 2017 3 | 113 | 25 | 138 |
| 2017 2 | 46 | 20 | 66 |
| 2016 1 | 53 | 16 | 69 |
| 2016 12 | 43 | 10 | 53 |
| 2016 11 | 75 | 22 | 97 |
| 2016 10 | 104 | 23 | 127 |
| 2016 9 | 76 | 16 | 92 |
| 2016 8 | 50 | 4 | 54 |
| 2016 7 | 34 | 7 | 41 |
| 2016 6 | 11 | 10 | 21 |
| 2016 5 | 7 | 8 | 15 |
| 2016 4 | 10 | 5 | 15 |
| 2016 3 | 6 | 1 | 7 |
| 2016 2 | 7 | 1 | 8 |
| 2015 1 | 11 | 1 | 12 |
| 2015 12 | 8 | 1 | 9 |
| 2015 11 | 7 | 10 | 17 |
| 2015 10 | 3 | 8 | 11 |
| 2015 9 | 8 | 3 | 11 |
| 2015 8 | 9 | 1 | 10 |
| 2015 7 | 28 | 9 | 37 |
| 2015 6 | 40 | 5 | 45 |
| 2015 5 | 44 | 4 | 48 |
| 2015 4 | 18 | 9 | 27 |
| 2015 3 | 28 | 8 | 36 |
| 2015 2 | 15 | 12 | 27 |
| 2015 1 | 18 | 4 | 22 |
| 2014 12 | 24 | 6 | 30 |
| 2014 11 | 19 | 8 | 27 |
| 2014 10 | 32 | 4 | 36 |
| 2014 9 | 16 | 9 | 25 |
| 2014 8 | 22 | 4 | 26 |
| 2014 7 | 13 | 7 | 20 |
| 2014 6 | 24 | 12 | 36 |
| 2014 5 | 29 | 33 | 62 |
Mostrar todo
